# Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

> **NCT03157154** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 259 (actual)

## Conditions studied

- Hemophilia

## Interventions

- **OTHER:** Non interventional study

## Key facts

- **NCT ID:** NCT03157154
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-27
- **Primary completion:** 2017-07-30
- **Final completion:** 2017-07-30
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03157154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03157154, "Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03157154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*